Statements of Operations Clause Samples

The Statements of Operations clause outlines the requirement for a party, typically a company, to provide detailed reports of its financial performance over a specific period. This clause generally specifies the format, frequency, and content of such statements, which may include revenues, expenses, and net income. By mandating regular and standardized financial disclosures, the clause ensures transparency and enables stakeholders to assess the ongoing financial health and operational results of the entity.
Statements of Operations for the three and six months ended June 30, 1999 and 1998.......................... 4
Statements of Operations for the Years Ended December 31, 1998, 1997 and 1996..................................
Statements of Operations. 4 Statements of Stockholders' Equity (Deficit)................... 5
Statements of Operations. FISCAL YEARS ENDED ---------------------------------------- DECEMBER 28, DECEMBER 29, DECEMBER 31, 1997 1996 1995 ------------ ------------ ------------ Revenues............................. $ 60,510,538 $ 59,112,073 $ 36,939,042 Costs and Expenses: Cost of products sold.............. 22,489,664 23,134,739 14,947,274 Salaries and benefits.............. 21,278,451 19,104,993 13,336,589 General and administrative......... 29,074,560 27,057,608 20,744,802 Provision for store closures....... 2,688,259 -- -- ------------ ------------ ------------ Total costs and expenses......... 75,530,934 69,297,340 49,028,665 ------------ ------------ ------------ Loss from Operations................. (15,020,396) (10,185,267) (12,089,623) Other Income (Expense): Interest expense................... (4,078,383) (3,316,089) (2,153,661) Other income....................... 1,103,195 832,541 123,094 ------------ ------------ ------------ Total other expense.............. (2,975,188) (2,483,548) (2,030,567) ------------ ------------ ------------ Net loss............................. $(17,995,584) $(12,668,815) $(14,120,190) ============ ============ ============ The accompanying notes to financial statements are an integral part of these statements. F-69 BCE WEST, L.P. STATEMENTS OF PARTNERS' DEFICIT FOR THE YEARS ENDED DECEMBER 28, 1997, DECEMBER 29, 1996 AND DECEMBER 31, 1995
Statements of Operations for the Years Ended December 31, 1997 and December 31, 1996, and for the Period from Reactivation [December 31, 1994] through December 31, 1997...........................4 Statements of Cash Flows for the Years Ended December 31, 1997 and December 31, 1996, and for the Period from Reactivation [December 31, 1994] through December 31, 1997...........................5
Statements of Operations. 38 Statement of Stockholders' Equity........................... 39 Statements of Cash Flows.................................... 40 Notes to Financial Statements............................... 41 REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS The Board of Directors and Stockholders Sangamo BioSciences, Inc. We have audited the accompanying balance sheets of Sangamo BioSciences, Inc. as of December 31, 2000 and 1999, and the related statements of operations, stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2000. These financial statements are the responsibility of the company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Sangamo BioSciences, Inc. at December 31, 2000 and 1999, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2000, in conformity with accounting principles generally accepted in the United States. Palo Alto, California January 26, 2001 SANGAMO BIOSCIENCES, INC. BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS) ------------------- ASSETS 2000 -------- 1999 -------- Current assets: Cash and cash equivalents................................. $ 10,151 $ 251 Prepaid expenses.......................................... Total current assets.................................... 325 -------- 66,512 171 ------ 8,236 Property and equipment, net................................. 1,982 612 Other assets................................................ Total assets............................................ LIABILITIES AND STOCKHOLDERS' EQUITY 431 -------- $ 68,925 ======== 314 ------ $9,162 ====== Current liabilities: A...
Statements of Operations. 36 Statements of Changes in Net Assets...................... 37
Statements of Operations. FISCAL YEARS ENDED -------------------------------------- DECEMBER DECEMBER DECEMBER 28, 29, 31, 1997 1996 1995 ------------ ----------- ----------- Revenue................................ $ 58,307,231 $47,796,794 $30,183,858 Costs and Expenses: Cost of products sold................ 22,280,654 18,464,112 12,453,044 Salaries and benefits................ 17,294,186 15,693,832 11,342,794 General and administrative........... 28,150,053 20,141,197 12,882,659 Provision for store closures...
Statements of Operations. To reclassify estimated DMC charity care services of $81.5 million for the year ended June 30, 2009 and $61.1 million for the nine months ended March 31, 2010 to a revenue deduction instead of additional provision for doubtful accounts to be consistent with Vanguard’s presentation.
Statements of Operations. The unaudited pro forma condensed combined statements of operations for the six month period ended June 30, 2013 and the year ended December 31, 2012 reflect the following adjustments: